Liquid Chromatography Mass Spectrometer Offers Sensitivity and Speed
|
By LabMedica International staff writers Posted on 08 Aug 2012 |

Image: The Shimadzu LCMS-8080 high-end liquid chromatography mass spectrometer (Photo courtesy of Shimadzu).
A high-end liquid chromatography mass spectrometer (LCMS) that is sensitive, rapid, and accurate has been launched.
The new model, LCMS-8080 is an extension of the Ultra Fast Mass Spectrometry (UFMS) range. Its high speed capabilities will increase productivity in the laboratory by delivering accurate measurements, first time.
The new model can be used for a wide range of applications including clinical, environmental, and ADME laboratories, food safety testing, and drugs of abuse screening. The LCMS-8080’s sensitivity allows accurate quantitation of low level analytes.
The Coaxial Hot Gas Desolvation source is essential for the LCMS-8080’s sensitivity because it focuses the ion plume and improves ionization efficiency.
The model's compact footprint frees up the use of costly lab space, while its robust characteristics increase uptime by reducing instrument down time.
The liquid chromatography mass spectrometer is product of Shimadzu (Milton Keynes, UK). The MS-8080 can be rapidly installed using prepackaged methods. This means that individual components can easily be reused when new methods have been developed.
The LCMS-8080 is compatible with Nexera Ultra High Pressure Liquid Chromatography (UHPLC) which offers high carryover specifications and the highest pressure rating of any UHPLC. The high end instrument delivers stability and reliability in data acquisition, even when rapidly switching the ionization polarity.
Related Links:
Shimadzu
The new model, LCMS-8080 is an extension of the Ultra Fast Mass Spectrometry (UFMS) range. Its high speed capabilities will increase productivity in the laboratory by delivering accurate measurements, first time.
The new model can be used for a wide range of applications including clinical, environmental, and ADME laboratories, food safety testing, and drugs of abuse screening. The LCMS-8080’s sensitivity allows accurate quantitation of low level analytes.
The Coaxial Hot Gas Desolvation source is essential for the LCMS-8080’s sensitivity because it focuses the ion plume and improves ionization efficiency.
The model's compact footprint frees up the use of costly lab space, while its robust characteristics increase uptime by reducing instrument down time.
The liquid chromatography mass spectrometer is product of Shimadzu (Milton Keynes, UK). The MS-8080 can be rapidly installed using prepackaged methods. This means that individual components can easily be reused when new methods have been developed.
The LCMS-8080 is compatible with Nexera Ultra High Pressure Liquid Chromatography (UHPLC) which offers high carryover specifications and the highest pressure rating of any UHPLC. The high end instrument delivers stability and reliability in data acquisition, even when rapidly switching the ionization polarity.
Related Links:
Shimadzu
Latest Technology News
- AI Platform Links Biomarker Results to Cancer Clinical Trials and Guidelines
- Agentic AI Platform Supports Genomic Decision-Making in Oncology
- Algorithm Panel Aids Liver Fibrosis Assessment and Liver Cancer Surveillance
- Mailed Screening Kits Help Reduce Colorectal Cancer Screening Gaps
- AI-Enabled Assistant Unifies Molecular Workflow Planning and Support
- AI Tool Automates Validation of Laboratory Software Configuration Changes
- Point-of-Care Testing Enhances Health Literacy and Self-Management in Chronic Disease
- Fully Automated Sample-to-Insight Workflow Advances Latent TB Testing
- Tumor-on-a-Chip Platform Models Pancreatic Cancer Treatment Response
- New Platform Captures Extracellular Vesicles for Early Cancer Detection
- Microfluidic Single-Cell Assay Predicts Breast Cancer Risk
- AI Tool Predicts Non-Response to Targeted Therapy in Colorectal Cancer
- Integrated System Streamlines Pre-Analytical Workflow for Molecular Testing
- Noninvasive Sputum Test Detects Early Lung Cancer
- New AI Tool Enables Rapid Treatment Selection in Pediatric Leukemia
- Rapid Biosensor Detects Drug Sensitivity in Breast Tumors
Channels
Clinical Chemistry
view channel
Saliva-Based Test Detects Biochemical Signs of Sleep Loss
Acute sleep loss impairs cognition and motor skills, raising safety risks that resemble alcohol intoxication. Clinicians currently lack an objective biochemical test to determine when someone is dangerously... Read more
Simple Dual-Tau Blood Test Detects and Stages Alzheimer’s Disease
Alzheimer’s disease is typically confirmed and staged with positron emission tomography scans and cerebrospinal fluid testing, procedures that are costly and invasive. Broader access to minimally invasive... Read more
Alzheimer’s Blood Biomarkers Linked to Early Cognitive Differences Before Dementia
Blood-based screening for Alzheimer’s disease offers a noninvasive, lower-cost alternative to brain imaging or spinal fluid testing, yet its ability to flag the earliest cognitive changes has been unclear.... Read moreMolecular Diagnostics
view channel
New PCR Assay Supports Bundibugyo Ebola Outbreak Surveillance
Rapid identification of Ebola infections is essential to limit transmission and guide public health response, yet detection can be difficult when outbreaks involve rare variants. The current outbreaks... Read more
Plasma Protein Signature Predicts Lung Cancer Risk Up to Five Years Ahead
Lung cancer remains a leading cause of cancer death, and many cases are detected only after symptoms appear. Current screening programs largely target people with a history of smoking, leaving other at-risk... Read moreHematology
view channel
Next-Generation Hematology Platform Streamlines High-Complexity Lab Workflows
Sysmex America (Chicago, IL, USA) has introduced the next generation XR-Series, centered on the XR-10 Automated Hematology Module for high-complexity laboratories. The platform builds on the widely used... Read more
Blood Eosinophil Count May Predict Cancer Immunotherapy Response and Toxicity
Immune checkpoint inhibitors have improved outcomes across many cancers, yet only a subset of patients derive durable benefit and biomarkers to guide treatment remain limited. Eosinophils, best known for... Read moreImmunology
view channelAptamer-Based Biosensor Enables Mutation-Resilient SARS-CoV-2 Detection
Rapid evolution of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) can undermine existing molecular diagnostics, especially when assays target small viral components. Double-antibody sandwich... Read more
Study Points to Autoimmune Pathway Behind Long COVID Symptoms
Long COVID leaves many SARS-CoV-2 survivors with persistent fatigue, cognitive issues, palpitations, and musculoskeletal pain for months or years. Estimates cited in new research suggest 4%–20% of infected... Read more
Metabolic Biomarker Distinguishes Latent from Active Tuberculosis and Tracks Treatment Response
Tuberculosis (TB) remains the world’s leading infectious killer, with 10.8 million cases and 1.25 million deaths recorded globally in 2023. Yet many infected individuals never develop active disease, underscoring... Read moreMicrobiology
view channel
New Culture Medium Speeds C. difficile Resistance Detection and Reduces Costs
Clostridioides difficile infections remain a persistent threat in hospitals and communities, affecting about 500,000 people in the United States each year. Severe cases can be fatal within 30 days of diagnosis,... Read more
Automated Blood Culture System Speeds Detection of Bloodstream Infections
Bloodstream infections and sepsis require rapid laboratory detection to guide targeted antimicrobial therapy and reduce mortality. Conventional blood culture workflows can delay actionable results by critical... Read morePathology
view channel
3D Spatial Multi-Omics Maps Intra-Tumor Diversity in Colorectal Cancer
Colorectal cancer remains a leading cause of cancer death, and clinical decision-making is complicated by marked intra-tumor heterogeneity. Conventional bulk sequencing averages molecular signals across... Read more
Blood-Based Method Tracks Gene Activity in the Living Brain
Real-time measurement of gene activity in the brain has been limited by assays requiring destructive tissue sampling. Tracking active genes could reveal how the body responds to environmental factors,... Read moreIndustry
view channel
Collaboration Advances ctDNA-Guided Development in Metastatic Colorectal Cancer
Natera, Inc. (Austin, TX, USA) and CytoDyn Inc. (Vancouver, WA, USA) announced a strategic collaboration focused on metastatic colorectal cancer (mCRC). Under the agreement, Natera will evaluate circulating... Read more








